ESC 365 - Anticoagulation control, outcomes, and associated factors in patients with atrial fibrillation receiving warfarin at tertiary care hospital in ethiopia

CBS PREMIUM ACCESS

Anticoagulation control, outcomes, and associated factors in patients with atrial fibrillation receiving warfarin at tertiary care hospital in ethiopia

Session: Poster Session 1

Topic: Arrhythmias

Speaker: Assistant Professor T. Tadesse (Addis Ababa, ET)

Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

Add to my library

About the speaker

Assistant Professor Tamrat Assefa Tadesse

Addis Ababa University,, Addis Ababa (Ethiopia)

0 follower

73 more presentations in this session

Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients

Speaker: Miss E. Bevilacqua (Seville, ES)

Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring

Speaker: Doctor K. Viligorska (Chernivtsi, UA)

Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study

Speaker: Mr C. Rios Navarro (Valencia, ES)

Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion

Speaker: Associate Professor L. Tacu (Chisinau, MD)

Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets

Speaker: Doctor B. Agg (Budapest, HU)

Access the full session

Poster Session 1

Speakers: Assistant Professor T. Tadesse, Miss E. Bevilacqua, Doctor K. Viligorska, Mr C. Rios Navarro, Associate Professor L. Tacu...

About the event

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources